Skip to main content

Advertisement

SpringerLink
Log in

Definitive radiation therapy for invasive carcinoma of the vagina: impact of high-dose rate intracavitary brachytherapy

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

This study was designed to evaluate the efficacy of definitive radiation therapy (RT) for invasive carcinoma of the vagina.

Methods

Twenty-six patients with invasive carcinoma of the vagina who received RT were studied retrospectively. The median age was 68 years. The pathologic subtype of vaginal carcinoma was squamous cell carcinoma in 24 patients, adenosquamous cell carcinoma in one patient, and adenocarcinoma in one patient. The distribution of clinical stage according to the International Federation of Gynecology and Obstetrics staging system was as follows: stage I, seven patients; stage II, 10 patients, stage III, seven patients; and stage IVA, two patients. Twenty patients received external beam radiation therapy (EBRT) combined with high-dose rate intracavitary brachytherapy (HDR-ICBT), and three received EBRT alone. The remaining three patients with stage I disease were given HDR-ICBT alone. The median dose was 50 Gy for EBRT, and 23 Gy for HDR-ICBT. Systemic chemotherapy was administered concurrently with RT to three patients.

Results

The median follow-up was 90 months. The initial rate of response to RT was 100%, and complete remission was attained in 21 patients (81%). The 5-year overall survival rate (OS) and the median survival time of the 26 patients were 57% and 97 months, respectively. The 5-year OS for the three patients who received HDR-ICBT alone was 100%. Severe toxicity occurred in three patients—grade 3 rectal hemorrhage in one, grade 3 cystitis in one, and grade 4 cystitis in one.

Conclusions

Our results demonstrated that definitive RT with HDR-ICBT is effective for invasive carcinoma of the vagina, with acceptable toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Creasman WT, Phillips JL, Menck HR (1998) The National Cancer Data Base report on cancer of the vagina. Cancer 83(5):1033–1040

    Article  PubMed  CAS  Google Scholar 

  2. Beller U, Maisonneuve P, Benedet JL et al (2003) Carcinoma of the vagina. Int J Gynaecol Obstet 83(Suppl 1):27–39

    Article  PubMed  Google Scholar 

  3. Pecorelli S, Benedet JL, Creasman WT et al (1999) FIGO staging of gynecologic cancer. 1994–1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet 65(3):243–249

    Article  PubMed  CAS  Google Scholar 

  4. Cardenes HR, Perez CA (2008) Vagina. In: Halperin EC, Perez CA, Brady LW (eds) Perez and Brady’s principles and practice of radiation oncology, 5th edn. Lippincott Williams and Wilkins, Philadelphia, pp 1657–1681

    Google Scholar 

  5. Gay HA, Allison RR (2008) Vaginal cancer. In: Lu JJ, Brady LW (eds) Radiation oncology: an evidence-based approach. Springer, Berlin, pp 383–395

    Chapter  Google Scholar 

  6. Frank SJ, Jhingran A, Levenback C et al (2005) Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys 62(1):138–147

    Article  PubMed  Google Scholar 

  7. Nanavati PJ, Fanning J, Hilgers RD et al (1993) High-dose-rate brachytherapy in primary stage I and II vaginal cancer. Gynecol Oncol 51:67–71

    Article  PubMed  CAS  Google Scholar 

  8. Kucera H, Mock U, Knocke TH et al (2001) Radiotherapy alone for invasive vaginal cancer: outcome with intracavitary high dose rate brachytherapy versus conventional low dose rate brachytherapy. Acta Obstet Gynecol Scand 80:355–360

    PubMed  CAS  Google Scholar 

  9. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481

    Article  Google Scholar 

  10. Cancer Therapy Evaluation Program (2010) Common Terminology Criteria for Adverse Events (CTCAE) v4.0. http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_40. Accessed 30 June 2011

  11. Perez CA, Grigsby PW, Garipagaoglu M et al (1999) Factors affecting long-term outcome of irradiation in carcinoma of the vagina. Int J Radiat Oncol Biol Phys 44(1):37–45

    Article  PubMed  CAS  Google Scholar 

  12. Chyle V, Zagars GK, Wheeler JA et al (1996) Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors. Int J Radiat Oncol Biol Phys 35:891–905

    Article  PubMed  CAS  Google Scholar 

  13. Reddy S, Saxena VS, Reddy S et al (1991) Results of radiotherapeutic management of primary carcinoma of the vagina. Int J Radiat Oncol Biol Phys 21:1041–1044

    Article  PubMed  CAS  Google Scholar 

  14. Pingley S, Shrivastava SK, Sarin R et al (2000) Primary carcinoma of the vagina: TATA Memorial Hospital experience. Int J Radiat Oncol Biol Phys 46:101–108

    Article  PubMed  CAS  Google Scholar 

  15. Kirkbride P, Fyles A, Rawlings GA et al (1995) Carcinoma of the vagina—experience at the Princess Margaret Hospital (1974–1989). Gynecol Oncol 56(3):435–443

    Article  PubMed  CAS  Google Scholar 

  16. Perez CA, Arneson AN, Dehner LP et al (1974) Radiation therapy in carcinoma of the vagina. Obstet Gynecol 44(6):862–872

    PubMed  CAS  Google Scholar 

  17. Ogino I, Kitamura T, Okajima H et al (1998) High-dose-rate intracavitary brachytherapy in the management of cervical and vaginal intraepithelial neoplasia. Int J Radiat Oncol Biol Phys 40(4):881–887

    Article  PubMed  CAS  Google Scholar 

  18. Tewari KS, Cappuccini F, Puthawala AA et al (2001) Primary invasive carcinoma of the vagina: treatment with interstitial brachytherapy. Cancer 91(4):758–770

    Article  PubMed  CAS  Google Scholar 

  19. Dalrymple JL, Russell AH, Lee SW et al (2004) Chemoradiation for primary invasive squamous carcinoma of the vagina. Int J Gynecol Cancer 14(1):110–117

    Article  PubMed  CAS  Google Scholar 

  20. Nashiro T, Yagi C, Hirakawa M et al (2008) Concurrent chemoradiation for locally advanced squamous cell carcinoma of the vagina: case series and literature review. Int J Clin Oncol 13(4):335–339

    Article  PubMed  Google Scholar 

  21. Keys HM, Bundy BN, Stehman FB et al (1999) Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340(15):1154–1161 (Erratum in: N Engl J Med 1999;341(9):708)

    Article  PubMed  CAS  Google Scholar 

  22. Morris M, Eifel PJ, Lu J et al (1999) Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340(15):1137–1143

    Article  PubMed  CAS  Google Scholar 

  23. Rose PG, Bundy BN, Watkins EB et al (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340(15):1144–1153 (Erratum in: N Engl J Med 341(9):708)

    Article  PubMed  CAS  Google Scholar 

  24. Whitney CW, Sause W, Bundy BN et al (1999) Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17(5):1339–1348

    PubMed  CAS  Google Scholar 

  25. Alvarez RD, Soong SJ, Kinney WK et al (1989) Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix. Gynecol Oncol 35(2):130–135

    Article  PubMed  CAS  Google Scholar 

  26. Toita T, Nakano M, Higashi M et al (1995) Prognostic value of cervical size and pelvic lymph node status assessed by computed tomography for patients with uterine cervical cancer treated by radical radiation therapy. Int J Radiat Oncol Biol Phys 33(4):843–849

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Kanagawa Cancer Center, 1-1-2 Nakao Asahi-ku, Yokohama, Kanagawa, 241-0815, Japan

    Tetsuo Nonaka, Yuko Nakayama & Nobutaka Mizoguchi

  2. Department of Gynecologic Oncology, Kanagawa Cancer Center, Yokohama, Japan

    Ryo Onose, Hisamori Kato & Hiroki Nakayama

Authors
  1. Tetsuo Nonaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuko Nakayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nobutaka Mizoguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ryo Onose
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hisamori Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hiroki Nakayama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tetsuo Nonaka.

About this article

Cite this article

Nonaka, T., Nakayama, Y., Mizoguchi, N. et al. Definitive radiation therapy for invasive carcinoma of the vagina: impact of high-dose rate intracavitary brachytherapy. Int J Clin Oncol 18, 314–320 (2013). https://doi.org/10.1007/s10147-012-0379-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-012-0379-7

Keywords

Search

Navigation